tiprankstipranks
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market
RGBP
Regen Biopharma
RESEARCH TOOLSreports

Regen Biopharma (RGBP) Income Statement

123 Followers

Regen Biopharma Income Statement

Last quarter (Q1 2026), Regen Biopharma's total revenue was $59.06K, a decrease of 0.00% from the same quarter last year. In Q1, Regen Biopharma's net income was $-967.85K. See Regen Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 236.56K$ 236.56K$ 236.56K$ 235.52K$ 171.19K
Gross Profit
$ 236.56K$ 236.56K$ 236.56K$ 185.52K$ 146.19K
Operating Expenses
$ 575.10K$ 653.78K$ 923.51K$ 575.12K$ 346.96K
Depreciation and Amortization
$ 0.00$ 521.51K$ 1.90M$ 339.61K$ 200.77K
EBITDA
$ -338.54K$ -418.00K$ 3.12M$ 2.99M$ -6.20M
Operating Income
$ -338.54K$ -417.00K$ -687.00K$ -340.00K$ -201.00K
Other Income/Expenses
$ -935.96K$ -251.00K$ 1.84M$ 2.78M$ -6.56M
Pretax Income
$ -1.27M$ -668.00K$ 1.16M$ 2.44M$ -6.76M
Net Income
$ -1.27M$ -668.00K$ 1.02M$ 2.23M$ -6.76M
Per Share Metrics
Basic EPS
$ -0.05$ -0.16$ 0.14$ 0.36$ -1.69
Diluted EPS
$ -0.05$ -0.16$ 0.14$ 0.36$ -1.69
Weighted Average Shares Outstanding
 23.52M 4.11M 7.07M 3.14M 2.01M
Weighted Average Shares Outstanding (Diluted)
 23.52M 4.11M 7.07M 3.14M 2.01M
Currency in USD

Regen Biopharma Earnings and Revenue History